申请人:GLAXO GROUP LTD
公开号:WO2011025799A1
公开(公告)日:2011-03-03
Disclosed are 3-aminopyrrolidines of Formula (I) having pharmacological activity, pharmaceutical compositions containing them, and methods for the treatment of diseases mediated by the cathepsin C enzyme such as chronic obstructive pulmonary disease.
揭示了具有药理活性的式(I)的3-氨基吡咯烷,包含它们的药物组合物,以及用于治疗由cathepsin C酶介导的疾病(如慢性阻塞性肺病)的方法。